Skip to main content
Year archive

Mithra Pharmaceuticals S.A. — 2021 filings

All 59 regulatory filings released by Mithra Pharmaceuticals S.A. (MITRA) in 2021, sourced directly from the official regulator.

59 Filings
2021 Period
2021 filings (59)
Filing Released Lang
Mithra Issues a Put Option Notice Under Capital Agreement with LDA Capital
AGM Information
2021-12-20 English
Mithra exerce une option de vente en vertu de l'accord d'engagement de capital avec LDA Capital
Share Issue/Capital Change
2021-12-20 French
2021-11-10-Denominator change-EN.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-11-10 English
2021-11-10-Denominator change-FR.pdf
Share Issue/Capital Change
2021-11-10 French
Mithra Provides FDA Update on Myring®
Regulatory Filings
2021-10-06 English
Mithra annonce un update de la FDA concernant Myring®
Regulatory Filings
2021-10-06 French
2021-09-25-First half 2021 financial report EN.pdf
Interim / Quarterly Report H1 2021
2021-09-24 English
2021-09-24-First half 2021 financial report FR.pdf
Interim / Quarterly Report H1 2021
2021-09-24 French
Mithra Announces an Update on PeriNesta®
Regulatory Filings
2021-09-21 English
Mithra annonce un update sur PeriNesta®
Regulatory Filings
2021-09-21 French
Donesta® Phase III: Recruitment Completion of American Study and Additional Recruitment in the European Study
Earnings Release Q3 2021
2021-09-21 English
Phase III Donesta® : Clôture du recrutement pour l’étude nord-américaine et recrutement additionnel pour l’étude européenne
Regulatory Filings
2021-09-21 French
NEXTSTELLIS® RECEIVES FDA MARKETING EXCLUSIVITY AND PHASE III DATA PUBLISHED
Regulatory Filings
2021-05-27 English
NEXTSTELLIS® REÇOIT L’EXCLUSIVITÉ COMMERCIALE DE LA FDA ET VOIT SES DONNEES DE PHASE III PUBLIÉES
Regulatory Filings
2021-05-27 French
Mithra Announces European Approval of Estelle®
Regulatory Filings
2021-05-20 English
Mithra annonce l’approbation d’Estelle® en Europe
Regulatory Filings
2021-05-20 French
2021-05-20-New Board of Directors-EN.pdf
AGM Information
2021-05-20 English
2021-05-20-New board of Directors-FR.pdf
AGM Information
2021-05-20 French
2021-05-06-Change Denominator-EN.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-05-06 English
2021-05-06-Change Denominator-FR.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-05-06 French
2-2021-05-20-Agenda-EN.pdf
AGM Information
2021-04-20 English
3-2021-05-20-Explanatory Note-EN.pdf
AGM Information
2021-04-20 English
2021-05-20-Rapport de gestion FR.pdf
AGM Information
2021-04-20 French
4-2021-05-20-Notice of attendance-EN.pdf
AGM Information
2021-04-20 English
Rapport du CA - Augmentation K.pdf
Capital/Financing Update
2021-04-20 French
5-2021-05-20-Proxy-EN.pdf
Proxy Solicitation & Information Statement
2021-04-20 English
6-2021-05-20-Vote par correspondance-FR.pdf
AGM Information
2021-04-20 French
2021-05-20-Remuneration Policy- EN.pdf
Remuneration Information
2021-04-20 English
2021-05-20-Remuneration Policy- FR.pdf
Remuneration Information
2021-04-20 French
6-2021-05-20-Voting by mail-EN.pdf
AGM Information
2021-04-20 English
Comptes Annuels BNB 2020 Mithra.pdf
Annual Report FY 2020
2021-04-20 French
2021-05-20-Rapport de gestion EN.pdf
AGM Information
2021-04-20 English
Mithra Pharmaceuticals_RAG STAT_31 12 20 DEF.pdf
Audit Report / Information FY 2020
2021-04-20 French
CV Amel Tounsi.pdf
Governance Information
2021-04-20 English
5-2021-05-20-Procuration-FR.pdf
Proxy Solicitation & Information Statement
2021-04-20 French
CV An Cloet.pdf
Board/Management Information
2021-04-20 English
4-2021-05-20-Avis de participation-FR.pdf
AGM Information
2021-04-20 French
CV Valérie Gordenne.pdf
Board/Management Information
2021-04-20 English
3-2021-05-20-Notice explicative-FR.pdf
Proxy Solicitation & Information Statement
2021-04-20 French
Liesbeth Weynants_HRM Brussels_English.pdf
Board/Management Information
2021-04-20 English
2-2021-05-20-Agenda-FR.pdf
AGM Information
2021-04-20 French
1-2021-05-20-Convening Notice MITHRA-EN.pdf
AGM Information
2021-04-20 English
1-2021-05-20-Convocation AG MITHRA-FR.pdf
AGM Information
2021-04-20 French
Mithra Releases 2020 Annual Report and Invitation to its Securities holders’ Meeting
AGM Information
2021-04-20 English
Mithra publie son rapport annuel 2020 et l’invitation à son assemblée générale des détenteurs de titres
AGM Information
2021-04-20 French
2020-Annual-Report-Mithra-EN.pdf
Annual Report FY 2020
2021-04-20 English
2020-Rapport-Annuel-Mithra-FR.pdf
Annual Report FY 2020
2021-04-20 French
2021-04-16-Transparency-Notification-Alychlo-EN.pdf
Major Shareholding Notification
2021-04-16 English
2021-04-16-Transparency-Notification-Alychlo-FR.pdf
Major Shareholding Notification
2021-04-16 French
MAYNE PHARMA AND MITHRA ANNOUNCE FDA APPROVAL OF NEW ORAL CONTRACEPTIVE ESTELLE®
Regulatory Filings
2021-04-15 English
MAYNE PHARMA ET MITHRA ANNONCENT L'APPROBATION PAR LA FDA DU CONTRACEPTIF ESTELLE®
Regulatory Filings
2021-04-15 French
2021-03-09 Annual Results-EN.pdf
Earnings Release FY 2020
2021-03-09 English
2021-03-09 Annual Results-FR.pdf
Earnings Release FY 2020
2021-03-09 French
Mithra and Searchlight Pharma Announce Estelle® Approval in Canada
Regulatory Filings
2021-03-08 English
Mithra et Searchlight Pharma annoncent l’approbation d’Estelle® au Canada
Regulatory Filings
2021-03-08 French
The Board of Directors appoints Leon Van Rompay as CEO ad interim
Board/Management Information
2021-02-04 English
Le Conseil d’administration nomme Leon Van Rompay au poste de CEO ad interim
Board/Management Information
2021-02-04 French
Nomination of Christophe Maréchal as interim CEO
Board/Management Information
2021-01-21 English
Nomination de Christophe Maréchal en tant que CEO ad interim
Board/Management Information
2021-01-21 French